# Morphoceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/morphoceuticals

- Industry: Biotechnology
- Headquarters: Boston, US
- Website: www.morphoceuticals.com
- Total disclosed funding: $9.8M
- Latest round: Seed (Jan 13, 2023)
- Investors on record: 2

## About

Based in Boston, US, and founded in 2022 by Michael Levin and David Kaplan, Morphoceuticals operates as a biotechnology company that targets native bioelectric signaling to reprogram biology to help treat complex health states. In January 2023, Morphoceuticals, Inc. raised USD 9.8 million in seed funding co-led by new investor Prime Movers Lab and Juvenescence Limited.

The company uses artificial intelligence and a proprietary combination of ion channel and gap junction modulators to regenerate limbs, repair tissues, improve amputation stump health, regenerate organs, promote organ regeneration, and treat channelopathies with artificial intelligence-guided electroceuticals.

The company intends to use the January 2023 funding for further product development and business expansion.

## Funding rounds

- Seed, Jan 13, 2023, $9.8M — Juvenescence Therapeutics Limited, Prime Movers Lab

## Investors

- Juvenescence Therapeutics Limited — Seed
- Prime Movers Lab (https://capitalatlas.ai/funds/prime-movers-lab) — Seed